First Header Logo Second Header Logo

Stephen Tatter

Concepts (375)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery
61
2020
316
8.310
Why?
Brain Neoplasms
69
2021
581
7.450
Why?
Neoplasm Recurrence, Local
21
2020
337
2.400
Why?
Glioma
15
2021
132
1.980
Why?
Meningioma
10
2020
50
1.560
Why?
Trigeminal Neuralgia
9
2019
33
1.380
Why?
Meningeal Neoplasms
8
2017
45
1.330
Why?
Middle Aged
86
2020
10805
1.320
Why?
Retrospective Studies
49
2020
3100
1.300
Why?
Treatment Outcome
45
2020
3094
1.260
Why?
Laser Therapy
6
2020
51
1.250
Why?
Glioblastoma
12
2020
143
1.180
Why?
Salvage Therapy
16
2020
118
1.150
Why?
Adult
67
2020
8391
1.150
Why?
Aged
69
2020
9461
1.130
Why?
Female
91
2020
18112
1.070
Why?
Humans
112
2020
28998
1.060
Why?
Male
84
2020
17767
1.030
Why?
Parkinson Disease
9
2020
66
0.970
Why?
Intracranial Arteriovenous Malformations
3
2012
18
0.880
Why?
Magnetic Resonance Imaging
18
2018
1216
0.870
Why?
Deep Brain Stimulation
8
2020
46
0.870
Why?
Antineoplastic Agents, Alkylating
5
2018
40
0.860
Why?
Postoperative Complications
6
2019
670
0.800
Why?
Antineoplastic Agents
9
2020
546
0.790
Why?
Drug Delivery Systems
5
2021
92
0.790
Why?
Negative-Pressure Wound Therapy
4
2016
43
0.790
Why?
Cerebellar Neoplasms
2
2019
11
0.780
Why?
Follow-Up Studies
26
2020
2105
0.780
Why?
Aged, 80 and over
33
2020
3712
0.740
Why?
Cranial Irradiation
9
2020
84
0.740
Why?
Brain
6
2015
928
0.730
Why?
Hemangioblastoma
1
2019
4
0.690
Why?
von Hippel-Lindau Disease
1
2019
5
0.690
Why?
Neurosurgical Procedures
4
2015
97
0.610
Why?
Carmustine
3
2015
8
0.600
Why?
Combined Modality Therapy
11
2018
523
0.600
Why?
Dura Mater
2
2012
14
0.540
Why?
Stereotaxic Techniques
5
2020
23
0.520
Why?
Convection
3
2021
7
0.510
Why?
Treatment Failure
12
2020
159
0.500
Why?
Young Adult
17
2020
2398
0.490
Why?
Corpus Striatum
3
2020
60
0.470
Why?
Radiotherapy
6
2018
74
0.460
Why?
Disease-Free Survival
10
2020
281
0.440
Why?
Craniocerebral Trauma
1
2012
56
0.430
Why?
Subthalamic Nucleus
5
2020
13
0.420
Why?
Facial Pain
5
2014
21
0.410
Why?
Radiotherapy, Adjuvant
3
2017
68
0.400
Why?
Survival Analysis
14
2020
440
0.390
Why?
Genetic Vectors
2
2010
118
0.390
Why?
Multiple Sclerosis
3
2019
43
0.380
Why?
Melanoma
6
2019
148
0.380
Why?
Survival Rate
11
2020
795
0.370
Why?
Radiation Injuries
5
2018
66
0.350
Why?
Serotonin
2
2020
35
0.350
Why?
Anticonvulsants
1
2009
63
0.350
Why?
Lung Neoplasms
5
2017
383
0.340
Why?
Neoplasms
4
2020
608
0.330
Why?
Radiotherapy Dosage
9
2017
98
0.320
Why?
Adolescent
11
2020
3248
0.310
Why?
Nomograms
4
2017
30
0.310
Why?
Dopamine
3
2020
223
0.300
Why?
Decision Making
2
2020
180
0.300
Why?
Prognosis
10
2020
1362
0.300
Why?
Hypothalamo-Hypophyseal System
4
2008
34
0.290
Why?
Brain Edema
4
2014
16
0.280
Why?
Child
8
2020
2209
0.280
Why?
Surgery, Computer-Assisted
4
2017
56
0.280
Why?
Thalamus
2
2015
39
0.250
Why?
Glutamate Decarboxylase
2
2017
17
0.250
Why?
Postural Balance
1
2016
160
0.240
Why?
Benzenesulfonates
1
2003
3
0.240
Why?
Iodine Radioisotopes
1
2003
18
0.240
Why?
Brachytherapy
1
2003
22
0.230
Why?
Pesticides
1
2016
189
0.230
Why?
Catheterization
1
2003
58
0.230
Why?
Occupational Exposure
1
2016
224
0.230
Why?
Emigrants and Immigrants
1
2016
235
0.220
Why?
Central Nervous System Neoplasms
2
2014
28
0.220
Why?
Transients and Migrants
1
2016
281
0.220
Why?
Neurons
3
2015
394
0.220
Why?
Adenocarcinoma
2
2017
301
0.220
Why?
Brain Injuries
2
2014
94
0.220
Why?
Radiotherapy Planning, Computer-Assisted
2
2012
28
0.220
Why?
Breast Neoplasms
4
2017
666
0.210
Why?
Cerebral Angiography
2
2012
51
0.210
Why?
Carcinoma, Squamous Cell
2
2013
142
0.210
Why?
Astrocytoma
3
2018
30
0.200
Why?
Receptor, EphA2
1
2021
12
0.200
Why?
Radiation Dosage
5
2020
72
0.190
Why?
Sulfones
1
2020
14
0.190
Why?
Genomics
2
2018
82
0.190
Why?
Indans
1
2020
25
0.190
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2020
39
0.190
Why?
Registries
2
2020
278
0.190
Why?
Arnold-Chiari Malformation
2
2010
8
0.180
Why?
Neoplasm Metastasis
2
2018
199
0.180
Why?
Brain Diseases
1
2020
40
0.180
Why?
Craniotomy
3
2017
44
0.180
Why?
Carcinoma
1
2020
87
0.180
Why?
Hispanic Americans
1
2016
904
0.180
Why?
Visual Perception
1
2020
112
0.180
Why?
Trigeminal Nerve
2
2010
5
0.180
Why?
Hydrocortisone
4
2008
61
0.180
Why?
Prospective Studies
7
2019
2010
0.170
Why?
Movement Disorders
2
2010
25
0.170
Why?
Reward
2
2018
61
0.170
Why?
Pain Measurement
4
2014
360
0.170
Why?
Costs and Cost Analysis
1
2018
88
0.160
Why?
Multivariate Analysis
6
2018
636
0.160
Why?
Feedback, Psychological
1
2018
5
0.160
Why?
Cohort Studies
5
2019
1674
0.160
Why?
Pituitary Gland
2
2008
9
0.160
Why?
Disease Management
2
2017
114
0.160
Why?
Glomus Jugulare Tumor
1
2017
4
0.150
Why?
Basal Ganglia
2
2014
15
0.150
Why?
Medicare
1
2018
185
0.150
Why?
Neoplastic Stem Cells
1
2018
90
0.150
Why?
Time Factors
7
2017
1997
0.150
Why?
Brain Death
2
2017
27
0.150
Why?
Nervous System Neoplasms
1
2017
8
0.150
Why?
Weight Gain
2
2015
108
0.150
Why?
Signal Transduction
1
2020
666
0.150
Why?
Gastrointestinal Neoplasms
1
2017
32
0.150
Why?
Catheters, Indwelling
2
2009
40
0.150
Why?
Immunotherapy
1
2016
67
0.140
Why?
Spinal Cord Injuries
1
2016
32
0.140
Why?
Imaging, Three-Dimensional
1
2016
130
0.140
Why?
Risk Factors
7
2019
3509
0.140
Why?
Animals
11
2021
7296
0.140
Why?
Tremor
1
2015
10
0.140
Why?
Urinary Bladder Neoplasms
1
2018
179
0.130
Why?
Gene Transfer Techniques
2
2017
69
0.130
Why?
Retreatment
3
2016
40
0.130
Why?
Ganglioglioma
1
2015
6
0.130
Why?
Drug Implants
1
2015
10
0.130
Why?
Central Nervous System Diseases
1
2015
11
0.130
Why?
Hypesthesia
2
2015
10
0.130
Why?
Neurofibromatosis 2
1
2015
5
0.130
Why?
Recombinant Fusion Proteins
3
2003
97
0.130
Why?
Proportional Hazards Models
5
2015
706
0.130
Why?
Carcinoma, Renal Cell
2
2017
108
0.130
Why?
Radiotherapy, Intensity-Modulated
2
2014
29
0.130
Why?
Choice Behavior
1
2015
83
0.130
Why?
Meningeal Carcinomatosis
1
2014
6
0.130
Why?
Incidence
4
2020
1105
0.120
Why?
Brain Stem Neoplasms
1
2014
4
0.120
Why?
Sheep
4
2008
221
0.120
Why?
Kidney Neoplasms
2
2017
191
0.120
Why?
Exotoxins
2
2003
9
0.120
Why?
Epidermal Growth Factor
2
2003
21
0.120
Why?
Diphtheria Toxin
2
2003
23
0.120
Why?
Vein of Galen Malformations
1
2013
4
0.120
Why?
Interleukin-13
2
2003
33
0.120
Why?
Carcinoma, Small Cell
1
2013
21
0.120
Why?
Smoking
1
2017
427
0.120
Why?
Cerebral Veins
1
2013
11
0.120
Why?
Tomography, X-Ray Computed
3
2014
871
0.120
Why?
Tumor Burden
4
2014
60
0.110
Why?
Influenza Vaccines
1
2014
78
0.110
Why?
Skull Base Neoplasms
1
2012
3
0.110
Why?
Cerebral Cortex
1
2014
140
0.110
Why?
Dose-Response Relationship, Radiation
4
2015
76
0.110
Why?
Spin Labels
1
2012
23
0.110
Why?
Fatal Outcome
1
2012
78
0.110
Why?
Radiotherapy, Computer-Assisted
1
2012
3
0.110
Why?
Carcinoma, Basal Cell
1
2012
27
0.110
Why?
Neoplasms, Radiation-Induced
1
2012
13
0.110
Why?
Scalp
1
2012
33
0.110
Why?
Skull
1
2012
45
0.110
Why?
Neurilemmoma
1
2012
14
0.110
Why?
Neoplasm Staging
3
2015
436
0.110
Why?
Nitrogen Mustard Compounds
1
2012
4
0.110
Why?
Small Cell Lung Carcinoma
1
2012
14
0.110
Why?
Lymphoma, Non-Hodgkin
1
2012
20
0.100
Why?
Arginine Vasopressin
2
2008
3
0.100
Why?
Resuscitation
1
2012
56
0.100
Why?
Procarbazine
1
2011
5
0.100
Why?
Collagen Diseases
1
2011
5
0.100
Why?
Angiogenesis Inhibitors
1
2011
34
0.100
Why?
Thalidomide
1
2011
29
0.100
Why?
Hyperthermia, Induced
1
2014
235
0.100
Why?
Double-Blind Method
3
2020
501
0.100
Why?
Disease Progression
3
2018
572
0.100
Why?
Viruses
1
2010
3
0.100
Why?
Algorithms
1
2014
461
0.100
Why?
Medulloblastoma
1
2010
7
0.100
Why?
Blood-Brain Barrier
1
2010
42
0.100
Why?
Vascular Diseases
1
2011
61
0.100
Why?
Radiation Oncology
1
2010
10
0.090
Why?
Posture
1
2010
53
0.090
Why?
Lymphoma
1
2010
36
0.090
Why?
Age Factors
1
2013
1105
0.090
Why?
Deglutition Disorders
1
2010
50
0.090
Why?
Fetus
3
2008
78
0.090
Why?
North Carolina
3
2016
1422
0.090
Why?
Cognition Disorders
1
2013
389
0.090
Why?
Cell Line, Tumor
3
2020
680
0.090
Why?
Case-Control Studies
2
2016
855
0.090
Why?
Cell Proliferation
3
2020
573
0.090
Why?
Recurrence
3
2015
235
0.080
Why?
Neurofibromatoses
1
2008
2
0.080
Why?
Mice, Nude
2
2020
276
0.080
Why?
Ablation Techniques
2
2018
24
0.080
Why?
Randomized Controlled Trials as Topic
1
2010
462
0.080
Why?
Databases, Factual
2
2020
331
0.080
Why?
Guanine
1
2007
14
0.080
Why?
Inositol 1,4,5-Trisphosphate
1
2006
7
0.070
Why?
Cobalt Radioisotopes
1
2006
2
0.070
Why?
Child, Preschool
3
2020
1164
0.070
Why?
Pregnancy, Animal
1
2006
19
0.070
Why?
Weight Loss
1
2010
413
0.070
Why?
Gestational Age
4
2008
95
0.070
Why?
Karnofsky Performance Status
2
2018
10
0.070
Why?
Receptors, Corticotropin
1
2005
2
0.070
Why?
Adrenal Glands
1
2005
4
0.070
Why?
Supratentorial Neoplasms
1
2004
3
0.060
Why?
Swine
2
2016
201
0.060
Why?
Fetal Development
1
2004
25
0.060
Why?
Adenoviridae
1
2004
61
0.060
Why?
Transforming Growth Factor alpha
1
2003
4
0.060
Why?
DNA Methylation
2
2015
129
0.060
Why?
Cause of Death
2
2015
219
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2007
401
0.060
Why?
Pituitary Gland, Anterior
1
2003
2
0.060
Why?
Mice
2
2020
2368
0.060
Why?
Hypothalamus
1
2003
18
0.060
Why?
Sheep, Domestic
1
2003
18
0.060
Why?
Renin-Angiotensin System
1
2004
182
0.060
Why?
Adrenocorticotropic Hormone
3
2008
22
0.060
Why?
Equipment Design
1
2003
167
0.060
Why?
Pregnancy
4
2008
807
0.060
Why?
Analysis of Variance
2
2017
454
0.060
Why?
Quality of Life
3
2018
814
0.060
Why?
Feasibility Studies
1
2003
262
0.050
Why?
Intracranial Hemorrhages
2
2013
31
0.050
Why?
Rats, Sprague-Dawley
2
2016
747
0.050
Why?
Disease Models, Animal
2
2016
980
0.050
Why?
Cytotoxins
1
2021
11
0.050
Why?
Dogs
1
2021
117
0.050
Why?
Prevalence
2
2014
892
0.050
Why?
Dyskinesias
1
2020
3
0.050
Why?
Xenograft Model Antitumor Assays
1
2020
113
0.050
Why?
Rats
2
2016
1604
0.050
Why?
Photic Stimulation
1
2020
155
0.050
Why?
Cell Movement
1
2020
161
0.040
Why?
Predictive Value of Tests
2
2012
784
0.040
Why?
Receptors, Interleukin
3
2003
15
0.040
Why?
Risk
1
2020
289
0.040
Why?
United States
2
2018
3604
0.040
Why?
Postoperative Period
1
2018
91
0.040
Why?
Necrosis
1
2018
52
0.040
Why?
Transcriptional Activation
1
2018
42
0.040
Why?
Longitudinal Studies
1
2020
708
0.040
Why?
Neoplasm Transplantation
1
2018
76
0.040
Why?
Avoidance Learning
1
2018
18
0.040
Why?
Transplantation, Heterologous
1
2018
121
0.040
Why?
Neuronavigation
1
2017
8
0.040
Why?
Parvovirinae
1
2017
2
0.040
Why?
Hearing Tests
1
2017
11
0.040
Why?
Hospitalization
1
2020
417
0.040
Why?
Confidence Intervals
1
2017
140
0.040
Why?
Severity of Illness Index
1
2020
863
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2018
249
0.040
Why?
Blood Gas Analysis
2
2008
16
0.040
Why?
Diffusion Tensor Imaging
1
2016
29
0.040
Why?
Biopsy
1
2017
241
0.040
Why?
Games, Experimental
1
2015
4
0.030
Why?
Positron-Emission Tomography
1
2017
172
0.030
Why?
DNA Modification Methylases
1
2015
11
0.030
Why?
DNA Repair Enzymes
1
2015
16
0.030
Why?
Electrodes, Implanted
1
2015
40
0.030
Why?
Cells, Cultured
2
2008
799
0.030
Why?
Recovery of Function
1
2016
190
0.030
Why?
Spinal Cord
1
2016
139
0.030
Why?
Tumor Suppressor Proteins
1
2015
72
0.030
Why?
Reoperation
1
2015
203
0.030
Why?
Action Potentials
1
2015
174
0.030
Why?
Levodopa
1
2014
14
0.030
Why?
Influenza A Virus, H3N2 Subtype
1
2014
22
0.030
Why?
Influenza B virus
1
2014
20
0.030
Why?
Dacarbazine
1
2014
29
0.030
Why?
Brain Stem
1
2014
18
0.030
Why?
Models, Animal
1
2014
160
0.030
Why?
Fetal Blood
2
2005
35
0.030
Why?
Receptors, Interleukin-13
2
2003
9
0.030
Why?
Interleukin-13 Receptor alpha1 Subunit
2
2003
10
0.030
Why?
Hemorrhage
1
2014
90
0.030
Why?
Tumor Cells, Cultured
2
2003
158
0.030
Why?
Models, Neurological
1
2014
115
0.030
Why?
Cost-Benefit Analysis
1
2013
159
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2014
92
0.030
Why?
Pain
1
2015
282
0.030
Why?
Beta Rhythm
1
2012
1
0.030
Why?
Hypokinesia
1
2012
3
0.030
Why?
Antiparkinson Agents
1
2012
10
0.030
Why?
Embolization, Therapeutic
1
2013
79
0.030
Why?
Receptors, Progesterone
1
2012
45
0.030
Why?
Pilot Projects
1
2014
469
0.030
Why?
Receptor, erbB-2
1
2012
45
0.030
Why?
Regression Analysis
1
2013
272
0.030
Why?
Receptors, Estrogen
1
2012
89
0.030
Why?
Radiography
1
2013
353
0.030
Why?
Electric Stimulation
1
2012
102
0.030
Why?
RNA, Messenger
2
2005
514
0.030
Why?
Protein-Tyrosine Kinases
1
2012
37
0.030
Why?
Data Interpretation, Statistical
1
2012
103
0.030
Why?
Psychomotor Performance
1
2012
97
0.030
Why?
Radiometry
1
2012
39
0.030
Why?
Reproducibility of Results
1
2014
724
0.030
Why?
Pain, Postoperative
1
2014
173
0.030
Why?
Neuropsychological Tests
1
2013
378
0.030
Why?
Facial Paralysis
1
2011
7
0.030
Why?
Hydrocephalus
1
2011
13
0.030
Why?
Survivors
1
2013
144
0.030
Why?
Arthritis, Rheumatoid
1
2011
33
0.020
Why?
Otitis Media
1
2011
21
0.020
Why?
Pons
1
2010
7
0.020
Why?
Craniopharyngioma
1
2010
8
0.020
Why?
Spinal Nerve Roots
1
2010
14
0.020
Why?
Glial Fibrillary Acidic Protein
1
2010
37
0.020
Why?
Microtubule-Associated Proteins
1
2010
33
0.020
Why?
Pituitary Neoplasms
1
2010
17
0.020
Why?
Medical Records
1
2010
68
0.020
Why?
Emaciation
1
2010
4
0.020
Why?
Gastroesophageal Reflux
1
2010
25
0.020
Why?
Endoscopy
1
2010
40
0.020
Why?
Lupus Erythematosus, Systemic
1
2011
145
0.020
Why?
Essential Tremor
1
2010
12
0.020
Why?
Chi-Square Distribution
1
2010
292
0.020
Why?
Transplantation, Autologous
1
2009
78
0.020
Why?
Hydrogen-Ion Concentration
1
2008
66
0.020
Why?
Decompression, Surgical
1
2009
53
0.020
Why?
Injections, Intravenous
1
2008
73
0.020
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2007
1
0.020
Why?
Radioactivity
1
2006
2
0.020
Why?
Half-Life
1
2006
22
0.020
Why?
Infusions, Intravenous
1
2007
85
0.020
Why?
Mental Disorders
1
2008
103
0.020
Why?
Body Weight
1
2008
290
0.020
Why?
Asthma
1
2010
397
0.020
Why?
Adrenal Cortex
1
2005
2
0.020
Why?
Logistic Models
1
2007
725
0.020
Why?
Triiodothyronine
1
2004
7
0.020
Why?
Thyroxine
1
2004
16
0.020
Why?
Denervation
1
2004
13
0.020
Why?
Injections, Intralesional
1
2004
13
0.020
Why?
Adenovirus E1B Proteins
1
2004
12
0.020
Why?
Viral Vaccines
1
2004
13
0.020
Why?
Gene Expression Regulation, Developmental
1
2004
68
0.020
Why?
Receptors, Angiotensin
1
2004
77
0.020
Why?
Virus Replication
1
2004
47
0.020
Why?
Renin
1
2004
112
0.020
Why?
Inhibitory Concentration 50
1
2003
23
0.020
Why?
Pseudomonas
1
2003
6
0.020
Why?
Receptors, Interleukin-4
1
2003
6
0.010
Why?
Microscopy, Confocal
1
2003
62
0.010
Why?
Receptors, Transferrin
1
2003
10
0.010
Why?
Drug Screening Assays, Antitumor
1
2003
50
0.010
Why?
Drug Synergism
1
2003
67
0.010
Why?
Survival
1
2003
13
0.010
Why?
Receptors, Corticotropin-Releasing Hormone
1
2003
1
0.010
Why?
Maximum Tolerated Dose
1
2003
56
0.010
Why?
Flow Cytometry
1
2003
171
0.010
Why?
Receptors, Vasopressin
1
2003
7
0.010
Why?
Absorbable Implants
1
2003
24
0.010
Why?
Drug Resistance, Neoplasm
1
2003
89
0.010
Why?
Polymers
1
2003
59
0.010
Why?
Seizures
1
2003
59
0.010
Why?
Drug Therapy, Combination
1
2003
273
0.010
Why?
Dose-Response Relationship, Drug
1
2004
641
0.010
Why?
Clinical Trials as Topic
1
2004
298
0.010
Why?
Biocompatible Materials
1
2003
210
0.010
Why?
Gene Expression Regulation
1
2003
481
0.010
Why?
Tatter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (375)
Explore
_
Co-Authors (47)
Explore
_
Similar People (51)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_